Medical News

RSS

CareTech Solutions to demonstrate BoardNet at HIMSS10

CareTech Solutions (www.caretech.com), an information technology (IT) and Web products and services company serving U.S. hospitals and health systems, will showcase BoardNet™, the company's secure internet portal for hospital boards and administrators in its booth (Hall C; 1242) at HIMSS10 annual conference and exhibition at the World Congress Center in Atlanta, Georgia.

1 Mar 2010

Outpatient referrals from primary care physicians for CT, MRI studies inappropriate: Academic medical center

A large academic medical center has found that a significant percentage of outpatient referrals they receive from primary care physicians for computed tomography (CT) and magnetic resonance imaging (MRI) studies are inappropriate (based upon evidence-based appropriateness criteria developed by a radiology benefits management company), according to a study in the March issue of the Journal of the American College of Radiology (www.jacr.org).

1 Mar 2010

Ashton and Georgieva visit Haiti to evaluate development of European humanitarian aid

Catherine Ashton, High Representative of the Union for Foreign Affairs and Security Policy and Vice President of the European Commission, and Kristalina Georgieva, Commissioner for Humanitarian Aid and Civil Protection, will visit Haiti to evaluate the development of European humanitarian aid and assess future needs.

1 Mar 2010

CUTCO Cutlery recommits to Go Red For Women movement for another year

On the heels of its successful 2009 campaign, CUTCO Cutlery Corp. has announced it will recommit to the American Heart Association's Go Red For Women® movement for another year.

1 Mar 2010

Aprepitant drug can reduce nausea and vomiting when combined with other anti-nausea drugs

Bone marrow transplant patients say two of the most debilitating side effects of the treatment are nausea and vomiting caused by chemotherapy and radiation.

1 Mar 2010

ADVENTRX' ANX-530 NDA: FDA issues refuse to file letter

ADVENTRX Pharmaceuticals, Inc. announced today that it received a refuse to file letter from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for ANX-530 (vinorelbine injectable emulsion). In the letter, the FDA indicated that the data included in the initial submission from the intended commercial manufacturing site was insufficient to support a commercially-viable expiration dating period. FDA identified only the one chemistry, manufacturing and controls (CMC) reason for the refusal to file. ADVENTRX plans to meet with the FDA as soon as possible to discuss its response.

1 Mar 2010

Childhood obesity prevention: Prenatal and infancy period upto age 5 crucial

Efforts to prevent childhood obesity should begin far earlier than currently thought-perhaps even before birth-especially for minority children, according to a new study that tracked 1,826 women from pregnancy through their children's first five years of life.

1 Mar 2010

Short-term dose of losartan-M6PHSA reduces liver inflammation and fibrosis: Study

A recent study found that rats with advanced fibrosis that were administered a short-term dose of losartan-M6PHSA had reduced liver inflammation and fibrosis. Those animals treated with oral losartan alone did not experience a similar reduction in disease activity. Results of this study appear in the March issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.

1 Mar 2010

Obese children as young as 3 years old have elevated levels of C-reactive protein

A study by University of North Carolina at Chapel Hill researchers found that obese children as young as 3 years old have elevated levels of C-reactive protein, a marker of inflammation that in adults is considered an early warning sign for possible future heart disease.

1 Mar 2010

Diagosis of head and neck lesions: Ultrasound-guided FNA better than standard palpation technique

Office-based, surgeon-performed, ultrasound-guided, fine needle aspiration (FNA) of head and neck lesions yields a statistically significant higher diagnostic rate compared to the standard palpation technique, indicates new research in the March 2010 issue of Otolaryngology - Head and Neck Surgery.

1 Mar 2010

Growth rate among non-radiologists who own/lease PET equipment is on the rise: Study

Just as with computed tomography (CT) and magnetic resonance imaging (MRI), the growth rate among non-radiologists who own or lease positron emission tomography (PET) equipment is also on the rise, contributing significantly to the ongoing issues surrounding self-referral and unnecessary utilization of imaging in the United States, according to a study published in the March issue of the Journal of the American College of Radiology (www.jacr.org)

1 Mar 2010

NPS Pharmaceuticals supports second annual U.S. Rare Disease Day observance

NPS Pharmaceuticals, a specialty pharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, announced today its support for the second annual U.S. Rare Disease Day observance on February 28.

1 Mar 2010

Smoking cessation: New nicotine lung delivery technology promising

A novel technology for delivering nicotine to the lungs may soon give smokers a new way to kick the habit.

1 Mar 2010

Study shows ghrelin prevents acute liver damage, reduces oxidative stress and inflammation

Spanish researchers determined that rats treated with recombinant ghrelin displayed a reduction in liver fibrosis. Ghrelin, a stomach hormone, reduced the amount of fibrogenic cells by 25% in the treated rodents. Research further showed ghrelin prevented acute liver damage and reduced oxidative stress and inflammation in the animal models.

1 Mar 2010

Study associates frequent napping with elevated prevalence of type 2 diabetes in older Chinese population

A study in the March 1 issue of the journal Sleep shows that frequent napping is associated with an elevated prevalence of type 2 diabetes and impaired fasting glucose in an older Chinese population.

1 Mar 2010

FiberNet EPS has 97.5% success rate in patients undergoing CAS: EPIC study

A multicenter EPIC (FiberNet- Embolic Protection System in Carotid Artery Stenting Trial) study found that the FiberNet Embolic Protection System (EPS) had a 97.5% success rate when used in patients undergoing carotid artery stenting (CAS). Full findings are published early online in Catheterization and Cardiovascular Interventions, the official journal of The Society for Cardiovascular Angiography and Interventions.

1 Mar 2010

Sen. Kyl says Republicans will support temporary COBRA extension

The Hill: "The Senate will pass the stalled temporary extension of certain unemployment benefits but a yearlong extension might be a tougher sell, Senate Minority Whip Jon Kyl (R-Ariz.) said Sunday. Republicans and Democrats had reached an agreement on the temporary extension last week but Sen. Jim Bunning (R-Ky.)

1 Mar 2010

[11C]PiB PET neuroimaging exhibits potential for monitoring therapeutics on amyloid beta load during Alzheimer’s disease treatment

Elan Corporation, plc today announced that findings from a Phase II study which suggested bapineuzumab reduced amyloid-beta deposits in the brains of Alzheimer’s disease patients as measured using a neuroimaging technique known as [11C]PiB PET, were published in the February 28, 2010 online edition of Lancet Neurology. Bapineuzumab is a compound under development by Pfizer and Janssen Alzheimer Immunotherapy, a Johnson & Johnson subsidiary in which Elan holds a minority equity interest.

1 Mar 2010

CareTech Solutions to showcase full IT service and eHealth Web portfolio at HIMSS10

CareTech Solutions (www.caretech.com), an information technology (IT) and Web products and services company serving U.S. hospitals and health systems, will showcase its full IT service and eHealth Web portfolio during HIMSS10 annual conference and exhibition at the World Congress Center in Atlanta, Georgia.

1 Mar 2010

Regular use of aspirin, acetaminophen and NSAIDs increases risk of hearing loss in men

In a study published in the March 2010 issue of The American Journal of Medicine, researchers determined that regular use of aspirin, acetaminophen and non-steroidal anti-inflammatory drugs (NSAIDs) increases the risk of hearing loss in men, particularly in younger men, below age 60.

1 Mar 2010

Medical News

CareTech Solutions to demonstrate BoardNet at HIMSS10

Outpatient referrals from primary care physicians for CT, MRI studies inappropriate: Academic medical center

Ashton and Georgieva visit Haiti to evaluate development of European humanitarian aid

CUTCO Cutlery recommits to Go Red For Women movement for another year

Aprepitant drug can reduce nausea and vomiting when combined with other anti-nausea drugs

ADVENTRX' ANX-530 NDA: FDA issues refuse to file letter

Childhood obesity prevention: Prenatal and infancy period upto age 5 crucial

Short-term dose of losartan-M6PHSA reduces liver inflammation and fibrosis: Study

Obese children as young as 3 years old have elevated levels of C-reactive protein

Diagosis of head and neck lesions: Ultrasound-guided FNA better than standard palpation technique

Growth rate among non-radiologists who own/lease PET equipment is on the rise: Study

NPS Pharmaceuticals supports second annual U.S. Rare Disease Day observance

Smoking cessation: New nicotine lung delivery technology promising

Study shows ghrelin prevents acute liver damage, reduces oxidative stress and inflammation

Study associates frequent napping with elevated prevalence of type 2 diabetes in older Chinese population

FiberNet EPS has 97.5% success rate in patients undergoing CAS: EPIC study

Sen. Kyl says Republicans will support temporary COBRA extension

[11C]PiB PET neuroimaging exhibits potential for monitoring therapeutics on amyloid beta load during Alzheimer’s disease treatment

CareTech Solutions to showcase full IT service and eHealth Web portfolio at HIMSS10

Regular use of aspirin, acetaminophen and NSAIDs increases risk of hearing loss in men

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News